by | Jun 3, 2026 | Brunner, Peter, Leuthardt, Eric, Tan, Gansheng
— Published date: 6/4/2026
Value Proposition: Brain-computer interface for monitoring and modulating neural states based on saccade-related neural dynamics.
Technology Description
Researchers at Washington University in St. Louis have developed a neurotechnology platform that monitors and modulat…
by | Jun 1, 2026 | DeSelm, Carl
— Published date: 6/2/2026
Value proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors.
Technology Desc…
by | May 28, 2026 | Chen, Ying, Kim, Yeawon
— Published date: 5/29/2026
Value Proposition: Urine-based biomarkers that can be used for early detection and diagnosis of kidney disease non-invasively.
Technology Description
Researchers at Washington University in St. Louis have identified three sensitive, urine-based biomarkers of kidney di…
by | May 22, 2026 | Baldelomar, Edwin, Bennett, Kevin
— Published date: 5/23/2026
Value Proposition: Method that uses non-contrast MRI to measure nephron number for individualized assessment of kidney functional capacity.
Technology Description
Researchers at Washington University in St. Louis have developed a method of using non-contrast MRI to d…
by | May 12, 2026 | Cui, Jianmin
— Published date: 5/13/2026
Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes.
Technology Description
Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…